RecruitingPhase 4NCT05718128
Clinical Study of Endocardial Myocardial Biopsy
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Enrollment
100 participants
Start Date
Jun 1, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
In this study, patients with endocardial myocardial biopsy were selected to observe the safety of the operation, and pathological examination was performed. If necessary, special tests such as viral examination, mass spectrometry and molecular biology were performed to confirm the diagnosis, and follow-up was performed.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria3
- Patients with no gender restriction, age 18-80 years old, receiving endocardial myocardial biopsy in the Second Affiliated Hospital of Zhejiang University School of Medicine;
- Patients with myocarditis, cardiomyopathy, heart failure and cardiac tumor of unknown clinical cause;
- Have the ability to understand the test, can cooperate with investigators.
Exclusion Criteria1
- Unable to understand or unwilling to fill in informed consent forms or follow visitors.
Interventions
PROCEDUREEndocardiomyocardial biopsy
Endocardiomyocardial biopsy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05718128
Related Trials
Mind Your Heart-II
NCT054311921 location
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288652 locations
ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
NCT071917301 location
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370641 locations
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT0700216420 locations